US20230248988A1 - Plasma deposition - Google Patents
Plasma deposition Download PDFInfo
- Publication number
- US20230248988A1 US20230248988A1 US18/299,844 US202318299844A US2023248988A1 US 20230248988 A1 US20230248988 A1 US 20230248988A1 US 202318299844 A US202318299844 A US 202318299844A US 2023248988 A1 US2023248988 A1 US 2023248988A1
- Authority
- US
- United States
- Prior art keywords
- application site
- deposition
- bone
- tooth
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000008021 deposition Effects 0.000 title claims abstract description 92
- 239000000463 material Substances 0.000 claims abstract description 101
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 60
- 239000012159 carrier gas Substances 0.000 claims abstract description 32
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 19
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 19
- 230000001404 mediated effect Effects 0.000 claims abstract description 18
- 238000000151 deposition Methods 0.000 claims description 99
- 238000000034 method Methods 0.000 claims description 52
- 239000000843 powder Substances 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 10
- 239000012620 biological material Substances 0.000 claims description 9
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- -1 flourapatite Chemical compound 0.000 claims description 5
- 229910052586 apatite Inorganic materials 0.000 claims description 4
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 239000000178 monomer Substances 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 239000012080 ambient air Substances 0.000 claims description 2
- 229910052589 chlorapatite Inorganic materials 0.000 claims description 2
- 230000002950 deficient Effects 0.000 claims description 2
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 1
- 238000007493 shaping process Methods 0.000 claims 1
- 230000007246 mechanism Effects 0.000 description 9
- 210000003298 dental enamel Anatomy 0.000 description 7
- 238000005137 deposition process Methods 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- 208000010392 Bone Fractures Diseases 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 210000004268 dentin Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 208000008558 Osteophyte Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004763 bicuspid Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 206010006514 bruxism Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002800 charge carrier Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/44—Applying ionised fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/042—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating using additional gas becoming plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C5/00—Filling or capping teeth
- A61C5/50—Implements for filling root canals; Methods or instruments for medication of tooth nerve channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C5/00—Filling or capping teeth
- A61C5/60—Devices specially adapted for pressing or mixing capping or filling materials, e.g. amalgam presses
- A61C5/62—Applicators, e.g. syringes or guns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00291—Anchoring means for temporary attachment of a device to tissue using suction
Definitions
- the present disclosure relates generally to tooth and bone restoration. More specifically, the present disclosure relates to restoring damaged portions of teeth or bone using plasma mediated deposition.
- Plasma techniques such as physical vapor deposition or plasma-enhanced chemical vapor deposition are known. Plasma-related techniques have been used in dentistry for sterilization and surface preparation to enhance adhesive properties of dental materials, but have not been used to restore damaged portions of teeth or bone. Other procedures that can halt advancing tooth decay or promote bone recovery, such as periodontal surgery, bone grafts, prosthesis implants, are often difficult, invasive and expensive to implement, and have limited, if any, success in actually restoring bone or enamel.
- a non-thermal plasma deposition device includes an ionization chamber configured to: receive a carrier gas and excite the carrier gas to form an ionizing plasma stream.
- the ionization chamber further comprises an inlet coupled to a restoration material supply, the inlet intersects with the ionization chamber in a location after the ionizing plasma stream is formed.
- the ionization chamber is further configured to receive the restoration material and introduce the restoration material into the ionizing plasma stream to form a deposition stream.
- the deposition nozzle is configured to eject a plume of the deposition stream to deposit the restoration material on an application site. The restoration material is thus deposited on and adhered to the application site via plasma mediated deposition. A shape and mechanical integrity of a damaged portion of a tooth or bone can thus be restored.
- the restoration material is hydroxylapatite (“HAP”), or a derivative thereof.
- HAP or derivatives thereof are primary constituents of organic bone material.
- Nano-scale powdered HAP when deposited via plasma mediated deposition, crystallizes and forms a structure that comports with a crystalline structure of the tooth or bone of the application site.
- a camera disposed proximate to the plume and directed towards the application site is used to capture images of the deposition of restoration material. Not only can such images be recorded for use during diagnosis and comparison, etc., but also such images can be used to provide vision of the deposition when such view may otherwise be obstructed.
- an exhaust hood is used to encapsulate the plume and application site. The exhaust structure may be coupled to a vacuum. Surrounding biological material can thus be protected. Residue of the deposition may also be vacated or vacuumed, etc., via an exhaust outlet in the exhaust hood.
- a method for repairing a damaged bone or tooth includes exciting a carrier gas to form an atmospheric plasma stream; and either (A) or (B). (A) introducing a restoration material into the plasma stream to form a deposition stream; and depositing the restoration material on an application site by ejecting a plume of the deposition stream to the application site. (B) Depositing the restoration material on an application site; and directing a plasma stream onto the restoration material on the application site. In either case, the application site is a damaged area of a tooth or bone.
- a method of repairing teeth or bone includes: affixing biocompatible nano-scale hydroxyapatite onto a damaged portion of a bone or tooth, wherein the hydroxyapatite is adhered via plasma mediated deposition using biocompatible gases, and wherein the plasma mediated deposition is conducted at a biocompatible temperature; and restoring a shape and a mechanical integrity of the damaged portion of the bone or tooth with the hydroxyapatite.
- FIG. 1 is a cross-sectional view of an exemplary non-thermal plasma deposition device.
- FIGS. 2 and 3 are flow diagrams of exemplary methodologies that facilitate restoring tooth or bone via plasma mediated deposition of restoration material.
- FIG. 4 is a cross-sectional view of an embodiment of the plasma deposition device with an exhaust structure.
- FIG. 5 is a cross-sectional view of an embodiment of the plasma deposition device with a camera and an exhaust structure.
- FIG. 6 is an SEM photo of non-thermal plasma deposited hydroxylapatite on a tooth substitute substrate.
- FIG. 7 is an SEM photo of several layers of non-thermal plasma deposited hydroxylapatite.
- the term “or” is intended to mean an inclusive “or” rather than an exclusive “or.” That is, unless specified otherwise, or clear from the context, the phrase “X employs A or B” is intended to mean any of the natural inclusive permutations. That is, the phrase “X employs A or B” is satisfied by any of the following instances: X employs A; X employs B; or X employs both A and B.
- the term “exemplary” is intended to mean serving as an illustration or example of something, and is not intended to indicate a preference.
- the articles “a,” “an,” and “the” should be interpreted to mean “one or more” unless the context clearly indicates the contrary.
- the term “includes” is used interchangeably with the term “comprising.”
- aspects described herein pertain to restoring damaged portions of tooth or bone using plasma mediated deposition.
- a biocompatible carrier gas is ionized to form a biocompatible atmospheric plasma.
- Restoration material is introduced into the plasma, which is then applied to a damaged portion of a bone or tooth.
- the restoration material is deposited on and is permanently affixed to the damaged portion of the bone or tooth, thus restoring a shape and mechanical integrity of the bone or tooth.
- NTP non-thermal plasma
- plasma refers to a partially or wholly ionized gas composed essentially of photons, ions and free electrons as well as atoms in their fundamental or excited states possessing a net neutral charge. Plasma possesses a net neutral charge because the number of positive charge carriers is equal to the number of negative ones.
- An NTP refers to a plasma that is near ambient temperature (e.g., from 20° C. to 60° C., or 25 ° C. to 40° C., or 22° C. to 30° C.) that is obtained at atmospheric or reduced pressures.
- remote treatment direct treatment, or electrode contact NTP may be used, also, afterglow or active plasma methods may be used.
- at least a partial vacuum is applied to enhance the process.
- the plasma deposition process does not include sputtering processes.
- plasma polymerization occurs where the restoration material is a polymerizable material (or monomer) that is introduced into the plasma stream.
- the NTP deposition device 100 comprises an ionization chamber 102 that is configured to receive a carrier gas and excite the carrier gas to form an ionizing plasma stream.
- the ionization chamber 102 further comprises carrier gas inlet 103 , and a restoration material inlet 104 that is configured to receive a restoration material, such as a bone or tooth restoration material, and introduce the restoration material into the ionizing plasma stream to form a deposition stream.
- the inlet 104 is coupled to the ionization chamber 102 and is disposed along a length of the ionization chamber 102 .
- the interior of the inlet 104 intersects with the interior of the ionization chamber 102 in a location between the ionizing plasma stream and a deposition nozzle 106 .
- the intersection is after the ionizing plasma stream has been activated.
- the inlet 104 is placed away from the electrode gap, such as at least 0.25 mm, at least 1 mm, or at least 5 mm from the electrode gap.
- a deposition nozzle 106 is configured to receive the deposition stream, and shape a plume of the deposition stream to conform to a desired application site 108 .
- the deposition nozzle 106 directs the deposition stream onto the application site 108 and deposits the restoration material onto the application site 108 via plasma mediated deposition of the plume of the deposition stream.
- the NTP deposition device 100 is dimensioned to be handheld and light enough for easy manipulation in small work areas such as a patient's mouth or a surgical incision. Form-factors similar to an endoscope or a wand used in 3-D imaging for dentistry may be utilized.
- the carrier gas is a biocompatible gas that is not harmful to tooth, bone, or surrounding biological tissue.
- the carrier gas can comprise, for example, helium, oxygen, nitrogen, argon, ambient air, or combinations thereof.
- the carrier gas is a non-reactive gas.
- Carrier gas is introduced into the ionization chamber 102 from a supply such as a pressure vessel or supply feed.
- a flow rate of the carrier gas into the ionization chamber 102 can be controlled by, for example a valve.
- the flow rate of the carrier gas into the ionization chamber can be restricted to 5 mL per minute to 15 L per minute, such as 500 mL per minute to 10 L per minute, or 1 L per minute to 5 L per minute.
- a desired flow rate for the carrier gas may depend on desired characteristics of the ionizing plasma stream as well as characteristics of the ionization chamber 102 .
- the ionization chamber 102 excites the carrier gas to form the ionizing plasma stream.
- subjecting the carrier gas to high energy ultraviolet light e.g., radiation having a wavelength between 180 nm to 270 nm
- microwaves e.g., radiation having a frequency of 2.4 GHz or more
- an electric discharge with a high voltage difference can result in the formation of an ionizing plasma.
- the ionization chamber 102 comprises a pair of electrodes, or an electrode and a grounded connection, which creates a voltage difference across the carrier gas within the ionization chamber 102 .
- a current source such as a 10 kHz, 20 kHz, or 40 kHz, or alternating current, can be used to drive the voltage difference.
- the voltage difference needed to excite the carrier gas may depend on the carrier gas selected, a shape of discharge needle, and an impedence matching network of the NTP deposition device 100 , and other factors.
- the plasma source is a capacitively coupled radio frequency (13.56) MHz discharge created the tip of a sharp needle.
- the macroscopic temperature of the ionizing plasma stream remains close to room temperature. This is because of low power consumption (e.g., 100 mW), convective cooling, and/or a small volume size of plasma ejected by the NTP deposition device 100.
- the plasma ejected from the NTP deposition device 100, the “plume,” has a small volume, (e.g., 0.01 mm 3 to 2 mm 3 , 0.1 mm 3 to 1 mm 3 , or 0.5 mm 3 to 1.5 mm 3 ) and a relatively large surface to volume ratio, which promotes energy escape by thermal diffusion.
- the inlet 104 in the ionization chamber 102 is also in communication with a feed of restoration material.
- the inlet 104 is coupled to a container with a supply of restoration material that may be pressurized, for example, the restoration material may be pumped, pushed, or gravity fed into the inlet 104 .
- the restoration material is aerosolized with a gas such as a carrier gas before being fed into the inlet 104 .
- the restoration material is a material that, when deposited on and affixed to tooth enamel, dentin, or bone, crystalizes and adheres to crystalline elements of the tooth enamel, dentin, or bone. By depositing the restoration material on a damaged portion of enamel, dentin, or bone, the damaged portion may thus be restored.
- the restoration material is a nano-scale powder suitable for being introduced into the ionizing plasma stream.
- the restoration material can comprise a variety of materials such as HAP, nano-scale diamonds, calcium apatite, or other minerals or materials.
- the restoration material is exclusive of zircon-oxide, poly(methyl methacrylate), polyethylene, metal, or glass.
- Calcium apatite, Ca 5 (PO 4 ) 4 (R), where R is an end-member, is a mineral produced and used by biological micro-environment systems.
- Species of calcium apatite include hydroxylapatite, Ca 5 (PO 4 ) 4 (OH) (“HAP”), flourapatite, Ca 5 (PO 4 ) 4 (F), and chlorapatite, Ca 5 (PO 4 ) 4 (Cl).
- Portions of bone material comprise HAP wherein many of the OH groups are missing and contain many carbonate and acid phosphate substitutions.
- the restoration material is a nano-scale powder of HAP, carbonated calcium-deficient HAP with acid phosphate substitutions, or derivatives or substitutions thereof.
- the manufactured nano-scale powders are dimensioned to approximately match a size of naturally occurring tooth enamel and bone crystals, for example 500 nm to 40 micrometers, such as 1 micrometer to 20 micrometers, or 2 micrometers to 10 micrometers.
- the size of the nano-scale powder may promote crystallization of the restoration material that conforms with a crystalline structure of tooth enamel or bone.
- the restoration material should have ionic bonding qualities needed to achieve a non-toxic, biocompatible, permanent reconstruction of tooth and/or bone. It was also surprisingly found that the NTP deposition process causes additional crystallization in the restoration material.
- the deposition nozzle 106 receives the deposition stream, and shapes the plume of the deposition stream to conform to a desired application site 108 .
- the plume is ejected proximate to the application site, thus depositing bone restoration material on the application site.
- a distance between the deposition nozzle 106 and the application site is selected such that bone restoration material adheres to, but does not damage the application site. Such distance may be calibrated based on, for example, a flow rate of the carrier gas, a flow rate of the restoration material, a size of the application site, and/or other factors.
- Example distances from the nozzle tip to the application site 108 include 0.001 mm to 5 mm, 0.01 mm to 3 mm, or 0.1 mm to 1.5 mm.
- the deposition nozzle 106 is configured to adjust a size and shape of the plume of the deposition stream.
- the inlet 104 may be external and intersect with the plasma stream after it passes through the deposition nozzle 106 .
- a desired application site 108 may be, for example, a dental cavity, a bone fracture, a bone spur, a weakened or damaged portion of a tooth or bone, a degenerated disk, an arthritic joint, a void (or chip) in a tooth or bone, a groove in a teeth, such as may be caused by severe bruxism, or a combination thereof.
- surgical techniques such as arthroscopic surgery may be adapted for use with the device 100 .
- an NTP deposition device 200 further comprises an exhaust hood 210 configured to vacate residue of the deposition stream from the application site 208 (which in this case is depicted as a cavity on a tooth surface) and/or provide at least a partial vacuum in the volume that is encompassed by the exhaust hood 210 and near the application site 208 .
- the volume under vacuum may extend from a terminal circumferential edge 212 of the exhaust hood 210 from 0.001 mm, to 5 mm, such as 0.01 mm to 2 mm, or 0.1 mm to 1 mm.
- the exhaust hood 210 uses suction or a vacuum to extract the residue.
- the exhaust hood 210 may be a cup, hood, skirt, funnel or another structure configured to encapsulate the deposition nozzle 106 and cover over the application site 208 so as to capture restoration material that does not adhere to bone or tooth and/or the ionized gasses in the deposition stream.
- the exhaust hood 210 may comprise a rigid or flexible material.
- the material may be a soft elastomeric material, a hard plastic material, a rigid metal material, or a soft, but stiff elastomer that will hold its form under vacuum, but will conform to the application site 208 if pushed against it.
- the exhaust hood 210 is co-axial with and coupled to the ionization chamber 106 or deposition nozzle 206 and circumscribing an area centered about the deposition nozzle 106 .
- a terminal circumferential edge 212 of the exhaust hood 210 may extend 0.1 mm to 5 mm in radius about the deposition nozzle 106 , such as 0.5 mm to 2 mm, or 1 mm to 1.5 mm.
- the terminal circumferential edge 212 may extend to be coplanar with a terminal end of the deposition nozzle 207 , or extend within 10 mm past a plane with the terminal end of the deposition nozzle 207 , such as 0.5 mm to 5 mm, or 1 mm to 1.5 mm.
- the terminal circumferential edge 212 of the exhaust hood 210 can be placed against the application site 208 so that the deposition nozzle 106 and the plume are substantially or completely encapsulated.
- the circumferential edge 212 of the exhaust hood 210 is from 0.001 mm to 5 mm in proximity to the application site 208 , such as 0.01 mm to 2 mm, or 0.1 mm to 1 mm.
- the circumferential edge 212 rests against the surrounding tissue or area around the application site 208 .
- the exhaust hood 210 is moveable in an axial direction along the outer surface of the ionizing chamber 102 and deposition nozzle 106 .
- the exhaust hood 210 may be coupled to the ionizing chamber 102 through a sliding mechanism or a sliding and locking mechanism.
- the exhaust hood 210 is concentrically fitted slideably coupled around the ionization chamber 102 and nozzle 106 .
- a tightened screw locking mechanism such as a thumb screw, may be coupled to the exhaust hood 210 and may be tightened against the ionization chamber 102 and untightened to lock and unlock the slideable coupling.
- the locking mechanism may be a tooth-in-groove structure or a reciprocating ratcheting mechanism.
- the exhaust hood 210 can be coupled to the ionizing chamber 102 through a tight fitting cap or ring that is slideable along the outer surface of the ionizing chamber 102 .
- the exhaust hood 210 is also configured to be locked into an axial position to prevent unwanted movement. This may be accomplished by known locking mechanisms for axially moveable parts, such as an insertable pin or lever that arrests movement in the axial direction. Axial rotation may also be prevented by known mechanisms including levers, pins, or detents.
- the vacuum exhaust outlet 213 is shown as extending up along the side of the ionization chamber 102 .
- the exhaust outlet may circumscribe the entire lower portion of the ionization chamber 102 or only partially circumscribe a portion of it.
- the exhaust outlet 213 is coupled to the exhaust hood 210 near the circumferential edge 212 of the exhaust hood 210 , such as 0.01 mm to 3 mm, 0.1 mm to 2 mm, or 0.5 mm to 1.5 mm from the circumferential edge 212 of the exhaust hood 210 .
- the exhaust outlet 213 is in communication with a vacuum device, such as an electric powered vacuum mechanism, or other known vacuum device.
- the vacuum suction power (or pressure) is adjustable to levels desired to produce a vacuum that removes loose material and/or reduces heat build-up in the affected area.
- the vacuum power is limited to a pressure that is less than a power that would disrupt the restoration material that is deposited onto the application site 208 .
- the vacuum power is high enough to affect the plasma deposition process, as certain plasma deposition processes may be enhanced in a vacuum environment.
- the vacuum power is enough to remove debris, but has no effect on the deposition process.
- the vacuum provides a drop from 99% to 1% of atmospheric pressure, e.g. (1 atm), such as 95% to 50%, or 90% to 75% of atmospheric pressure.
- the exhaust hood 210 may be adjustable so that the diameter of at least portions of the exhaust hood 210 , including the terminal circumferential edge 212 , can be increased or decreased. This may be accomplished by using a structure similar to a camera aperture. Where multiple overlapping curvilinear panels are utilized to form the hood structure.
- the exhaust hood 210 may be removable and replaceable with exhaust hoods of various shapes and features to adapt device 200 to the shape and conditions of the affected tooth, bone, or surrounding area.
- the edge of a tooth such as a bicuspid, may benefit from having an extended piece that wraps around the side of the tooth and where the vacuum exhaust outlet 213 is below the level of the application site 208 or to the side of the application site 208 .
- a structure similar to the exhaust hood 210 is coupled to the NTP deposition device 200 , but does not include any exhaust outlet 213 or vacuum mechanism.
- the protective hood operates to merely protect surrounding tissue from deflected deposition material and heat. This option may be useful for operating on an application site that is locally numbed, if proper care is taken.
- the protective hood may also be combined with the camera and adjustability features described herein.
- an NTP deposition device 300 can further comprise a camera 314 configured to capture images of the deposition of the restoration material on the application site 308 (in this example a bone surface with a chip or fracture).
- the camera 314 may capture still or moving images of the deposition of the restoration material. Captured images may be used to show a before/after change resulting from the deposition, or may be used in diagnosis or patient evaluation. Additionally, captured images can be used to provide the operator of the NTP deposition device 300 , such as a dentist, orthodontist, or surgeon with additional vision during the deposition process.
- a portion of the application site 308 may be obstructed from view of an individual using the NTP deposition device 300 by teeth, bone, other biological material, or the exhaust hood 210 .
- An obstructed view can inhibit the accuracy, efficiency, and precision of the deposition, and can lead to waste of materials such as carrier gas and/or restoration deposition material.
- Images captured from the camera 314 disposed on the NTP deposition device 300 can, for example, be transmitted to and displayed on a video display visible by the operator using the NTP deposition device.
- At least a portion of the camera 314 is disposed within the exhaust hood 210 .
- the exhaust hood 210 may obstruct the application site 308
- disposing the camera 314 within the exhaust hood 210 enables vision of the application site 308 while protecting surrounding biological material and evacuating residue of the deposition.
- Wiring or optical cables 316 for the camera 314 may run closely along the exterior of the device 300 .
- the camera 314 may be disposed opposite an exhaust outlet 213 within the exhaust hood 210 so as to reduce an amount of residue build-up on the camera 314 .
- FIGS. 4 and 5 various exemplary methodologies are illustrated and described. While the methodologies are described as being a series of acts that are performed in a sequence, it is to be understood that the methodologies are not limited by the order of the sequence. For instance, some acts may occur in a different order than what is described herein. In addition, an act may occur concurrently with another act. Furthermore, in some instances, not all acts may be required to implement a methodology described herein.
- the methodology 400 starts at 402 , and at 404 a carrier gas is excited to form an atmospheric plasma stream.
- the carrier gas is a biocompatible, non-toxic gas, and can be excited via various techniques such as, for example, being exposed to a voltage difference across an ionization chamber.
- a restoration material is introduced into the plasma stream to form a deposition stream.
- the restoration material is as described above, a material that, when deposited on tooth or bone, crystallizes with a structure that comports with a crystalline structure of the tooth or bone.
- the restoration material is a nano-scale powder of hydroxyapatite.
- the restoration material may be introduced into the plasma stream via a variety of techniques such as, for example, spraying, aerosolizing, or mixing.
- a plume of the deposition stream is directed to a desired application site.
- a nozzle shapes the plume to a size suitable for a particular application site such that surrounding biological material is protected from the deposition stream.
- restoration material is deposited on the application site by ejecting the plume proximate to the application site.
- images of depositing restoration material on the application site are captured.
- images may be captured, for example, by a camera directed towards the application site and disposed proximate to the plume.
- Restoration of the application site may include filling a void, such as a fracture, indentation, or crack back to its original state. For example, this may include filling the void up to a plane running across the highest edges of an indentation, fracture, or crack and possibly slightly exceeding the plane to substantially restore the original shape. For example, a crack may be filled within 10%, such as within 5%, or 2% of its volume or its distance over or beneath the plane.
- the restoration is not a mere thin coating on the surface of the application site, nor is it an adhesive by which additional material is added. Rather, the restoration deposition has a substantial thickness and fills up a voided area that has suffered the loss of original material that has abraded, broken, or otherwise decayed away. In an embodiment, the restoration deposition has a thickness of 0.001 mm to 35 mm, 0.1 mm to 5 mm, or 10 mm to 25 mm.
- residue of the deposition stream is vacated from the application site.
- the residue may be vacated by, for example, an exhaust hood, or vacuum, etc., disposed proximate to the plume.
- Residue may include, for example, excess restoration material, heat, and/or carrier gas.
- the methodology 500 starts at 502 , and at 504 , biocompatible nano-scale hydroxyapatite is adhered onto a damaged portion of a bone or tooth via biocompatible plasma mediated deposition.
- a shape and mechanical integrity of the damaged portion of tooth or bone is restored with the hydroxyapatite.
- biological material proximate to the damaged portion of tooth or bone is protected from the plasma mediated deposition.
- the methodology ends at 510 .
- the restoration material is introduced after the deposition nozzle.
- the restoration material may be deposited via a solution onto the application site and then ionized by the plasma gases that have no deposition material directly in the stream.
- a system or kit comprises a non-thermal plasma deposition device as disclosed herein.
- the system or kit also comprises one or more of the following: a restoration material, a supply container for the restoration material, a biocompatible carrier gas supply, a biocompatible carrier gas, an exhaust hood, a protective hood, a camera for capturing images of the restoration material deposition, a display for displaying the camera images, a vacuum device, a pressurization device, and conduits or wiring for connecting any of the components listed herein.
- the kit or system may be utilized to operate the methods for tooth or bone restoration disclosed herein.
- FIG. 6 shows an SEM photo that shows the hydroxylapatite restoration material deposited on and affixed to a Tagua surface, which is known to have similar properties to a human tooth. (See U.S. 2013/0224684, which is incorporated herein by reference for all purposes.)
- FIG. 7 is an SEM photo showing the hydroxylapatite crystals piling up in a significant thickness, such as would be useful to restore a damaged portion of tooth or bone by filling in a cracked, chipped, or otherwise damaged area.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Dentistry (AREA)
- Otolaryngology (AREA)
- Plasma & Fusion (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Materials For Medical Uses (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Abstract
Aspects described herein pertain to restoring damaged portions of tooth or bone using plasma mediated deposition. In an embodiment, a biocompatible carrier gas is ionized to form a biocompatible atmospheric plasma stream. Restoration material, such as nano-scale powdered hydroxyapatite, is introduced into the plasma stream, which is then applied to a damaged portion of a bone or tooth. The restoration material is deposited on the damaged portion of the bone or tooth, thus restoring a shape and mechanical integrity of the bone or tooth.
Description
- This application is a divisional of U.S. application Ser. No. 16/544,122, filed on Aug. 19, 2019, which, in turn, is a continuation of U.S. application Ser. No. 14/398,619, entitled “Tooth and Bone Restoration via Plasma Deposition,” which issued as U.S. Pat. No. 10,384,069 on Aug. 20, 2019, which is a national stage entry of PCT application PCT/US2014/012576, filed on Jan. 22, 2014, which, in turn, claimed priority to U.S. Provisional Application No. 61/755,092, filed Jan. 22, 2013, and entitled “TOOTH AND BONE RESTORATION METHOD AND DEVICE.” The entirety of these prior applications are incorporated herein by reference.
- The present disclosure relates generally to tooth and bone restoration. More specifically, the present disclosure relates to restoring damaged portions of teeth or bone using plasma mediated deposition.
- Plasma techniques such as physical vapor deposition or plasma-enhanced chemical vapor deposition are known. Plasma-related techniques have been used in dentistry for sterilization and surface preparation to enhance adhesive properties of dental materials, but have not been used to restore damaged portions of teeth or bone. Other procedures that can halt advancing tooth decay or promote bone recovery, such as periodontal surgery, bone grafts, prosthesis implants, are often difficult, invasive and expensive to implement, and have limited, if any, success in actually restoring bone or enamel.
- The following is a brief summary of subject matter that is described in greater detail herein. This summary is not intended to be limiting as to the scope of the claims.
- A non-thermal plasma deposition device, includes an ionization chamber configured to: receive a carrier gas and excite the carrier gas to form an ionizing plasma stream. The ionization chamber further comprises an inlet coupled to a restoration material supply, the inlet intersects with the ionization chamber in a location after the ionizing plasma stream is formed. The ionization chamber is further configured to receive the restoration material and introduce the restoration material into the ionizing plasma stream to form a deposition stream. The deposition nozzle is configured to eject a plume of the deposition stream to deposit the restoration material on an application site. The restoration material is thus deposited on and adhered to the application site via plasma mediated deposition. A shape and mechanical integrity of a damaged portion of a tooth or bone can thus be restored.
- In some embodiments, the restoration material is hydroxylapatite (“HAP”), or a derivative thereof. HAP or derivatives thereof are primary constituents of organic bone material. Nano-scale powdered HAP, when deposited via plasma mediated deposition, crystallizes and forms a structure that comports with a crystalline structure of the tooth or bone of the application site.
- In some embodiments, a camera disposed proximate to the plume and directed towards the application site is used to capture images of the deposition of restoration material. Not only can such images be recorded for use during diagnosis and comparison, etc., but also such images can be used to provide vision of the deposition when such view may otherwise be obstructed. In some embodiments, an exhaust hood is used to encapsulate the plume and application site. The exhaust structure may be coupled to a vacuum. Surrounding biological material can thus be protected. Residue of the deposition may also be vacated or vacuumed, etc., via an exhaust outlet in the exhaust hood.
- A method for repairing a damaged bone or tooth includes exciting a carrier gas to form an atmospheric plasma stream; and either (A) or (B). (A) introducing a restoration material into the plasma stream to form a deposition stream; and depositing the restoration material on an application site by ejecting a plume of the deposition stream to the application site. (B) Depositing the restoration material on an application site; and directing a plasma stream onto the restoration material on the application site. In either case, the application site is a damaged area of a tooth or bone.
- A method of repairing teeth or bone, the method includes: affixing biocompatible nano-scale hydroxyapatite onto a damaged portion of a bone or tooth, wherein the hydroxyapatite is adhered via plasma mediated deposition using biocompatible gases, and wherein the plasma mediated deposition is conducted at a biocompatible temperature; and restoring a shape and a mechanical integrity of the damaged portion of the bone or tooth with the hydroxyapatite.
- The above summary presents a simplified summary in order to provide a basic understanding of some aspects of the systems and/or methods discussed herein. This summary is not an extensive overview of the systems and/or methods discussed herein. It is not intended to identify key/critical elements or to delineate the scope of such systems and/or methods. Its sole purpose is to present some concepts in a simplified form as a prelude to the more detailed description that is presented later.
-
FIG. 1 is a cross-sectional view of an exemplary non-thermal plasma deposition device. -
FIGS. 2 and 3 are flow diagrams of exemplary methodologies that facilitate restoring tooth or bone via plasma mediated deposition of restoration material. -
FIG. 4 is a cross-sectional view of an embodiment of the plasma deposition device with an exhaust structure. -
FIG. 5 is a cross-sectional view of an embodiment of the plasma deposition device with a camera and an exhaust structure. -
FIG. 6 is an SEM photo of non-thermal plasma deposited hydroxylapatite on a tooth substitute substrate. -
FIG. 7 is an SEM photo of several layers of non-thermal plasma deposited hydroxylapatite. - Various technologies pertaining to restoring damaged portions of tooth or bone using plasma mediated deposition are now described with reference to the drawings, wherein like reference numerals are used to refer to like elements throughout. In the following description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of one or more aspects. It may be evident, however, that such aspect(s) may be practiced without these specific details. In other instances, structures and devices are shown in block diagram form in order to facilitate describing one or more aspects. Further, it is to be understood that functionality that is described as being carried out by certain components may be performed by multiple components. Similarly, for instance, a component may be configured to perform functionality that is described as being carried out by multiple components.
- Moreover, the term “or” is intended to mean an inclusive “or” rather than an exclusive “or.” That is, unless specified otherwise, or clear from the context, the phrase “X employs A or B” is intended to mean any of the natural inclusive permutations. That is, the phrase “X employs A or B” is satisfied by any of the following instances: X employs A; X employs B; or X employs both A and B. Additionally, as used herein, the term “exemplary” is intended to mean serving as an illustration or example of something, and is not intended to indicate a preference. The articles “a,” “an,” and “the” should be interpreted to mean “one or more” unless the context clearly indicates the contrary. The term “includes” is used interchangeably with the term “comprising.”
- Aspects described herein pertain to restoring damaged portions of tooth or bone using plasma mediated deposition. In a general embodiment, a biocompatible carrier gas is ionized to form a biocompatible atmospheric plasma. Restoration material is introduced into the plasma, which is then applied to a damaged portion of a bone or tooth. The restoration material is deposited on and is permanently affixed to the damaged portion of the bone or tooth, thus restoring a shape and mechanical integrity of the bone or tooth.
- With reference now to
FIG. 1 , an exemplary embodiment of a non-thermal plasma (“NTP”)deposition device 100 that facilitates restoration of tooth or bone is illustrated. The term “plasma” refers to a partially or wholly ionized gas composed essentially of photons, ions and free electrons as well as atoms in their fundamental or excited states possessing a net neutral charge. Plasma possesses a net neutral charge because the number of positive charge carriers is equal to the number of negative ones. An NTP refers to a plasma that is near ambient temperature (e.g., from 20° C. to 60° C., or 25° C. to 40° C., or 22° C. to 30° C.) that is obtained at atmospheric or reduced pressures. For example, remote treatment, direct treatment, or electrode contact NTP may be used, also, afterglow or active plasma methods may be used. In one embodiment at least a partial vacuum is applied to enhance the process. In an embodiment, the plasma deposition process does not include sputtering processes. In an embodiment of the device and process described herein plasma polymerization occurs where the restoration material is a polymerizable material (or monomer) that is introduced into the plasma stream. - As shown in
FIG. 1 , theNTP deposition device 100 comprises anionization chamber 102 that is configured to receive a carrier gas and excite the carrier gas to form an ionizing plasma stream. Theionization chamber 102 further comprisescarrier gas inlet 103, and arestoration material inlet 104 that is configured to receive a restoration material, such as a bone or tooth restoration material, and introduce the restoration material into the ionizing plasma stream to form a deposition stream. Theinlet 104 is coupled to theionization chamber 102 and is disposed along a length of theionization chamber 102. The interior of theinlet 104 intersects with the interior of theionization chamber 102 in a location between the ionizing plasma stream and adeposition nozzle 106. The intersection is after the ionizing plasma stream has been activated. In an embodiment utilizing internal electrodes theinlet 104 is placed away from the electrode gap, such as at least 0.25 mm, at least 1 mm, or at least 5 mm from the electrode gap. Adeposition nozzle 106 is configured to receive the deposition stream, and shape a plume of the deposition stream to conform to a desiredapplication site 108. Thedeposition nozzle 106 directs the deposition stream onto theapplication site 108 and deposits the restoration material onto theapplication site 108 via plasma mediated deposition of the plume of the deposition stream. - In an embodiment, the
NTP deposition device 100 is dimensioned to be handheld and light enough for easy manipulation in small work areas such as a patient's mouth or a surgical incision. Form-factors similar to an endoscope or a wand used in 3-D imaging for dentistry may be utilized. - The carrier gas is a biocompatible gas that is not harmful to tooth, bone, or surrounding biological tissue. The carrier gas can comprise, for example, helium, oxygen, nitrogen, argon, ambient air, or combinations thereof. In an embodiment, the carrier gas is a non-reactive gas. Carrier gas is introduced into the
ionization chamber 102 from a supply such as a pressure vessel or supply feed. A flow rate of the carrier gas into theionization chamber 102 can be controlled by, for example a valve. For example, the flow rate of the carrier gas into the ionization chamber can be restricted to 5 mL per minute to 15 L per minute, such as 500 mL per minute to 10 L per minute, or 1 L per minute to 5 L per minute. A desired flow rate for the carrier gas may depend on desired characteristics of the ionizing plasma stream as well as characteristics of theionization chamber 102. - The
ionization chamber 102 excites the carrier gas to form the ionizing plasma stream. For example, subjecting the carrier gas to high energy ultraviolet light, (e.g., radiation having a wavelength between 180 nm to 270 nm), microwaves (e.g., radiation having a frequency of 2.4 GHz or more), or an electric discharge with a high voltage difference can result in the formation of an ionizing plasma. In an example, theionization chamber 102 comprises a pair of electrodes, or an electrode and a grounded connection, which creates a voltage difference across the carrier gas within theionization chamber 102. A current source, such as a 10 kHz, 20 kHz, or 40 kHz, or alternating current, can be used to drive the voltage difference. The voltage difference needed to excite the carrier gas may depend on the carrier gas selected, a shape of discharge needle, and an impedence matching network of theNTP deposition device 100, and other factors. - In an embodiment the plasma source is a capacitively coupled radio frequency (13.56) MHz discharge created the tip of a sharp needle.
- While electron temperature may be very high, due to the excitation, the macroscopic temperature of the ionizing plasma stream remains close to room temperature. This is because of low power consumption (e.g., 100 mW), convective cooling, and/or a small volume size of plasma ejected by the
NTP deposition device 100. The plasma ejected from theNTP deposition device 100, the “plume,” has a small volume, (e.g., 0.01 mm3 to 2 mm3, 0.1 mm3 to 1 mm3, or 0.5 mm3 to 1.5 mm3) and a relatively large surface to volume ratio, which promotes energy escape by thermal diffusion. - The
inlet 104 in theionization chamber 102 is also in communication with a feed of restoration material. In an embodiment, theinlet 104 is coupled to a container with a supply of restoration material that may be pressurized, for example, the restoration material may be pumped, pushed, or gravity fed into theinlet 104. In an example, the restoration material is aerosolized with a gas such as a carrier gas before being fed into theinlet 104. - The restoration material is a material that, when deposited on and affixed to tooth enamel, dentin, or bone, crystalizes and adheres to crystalline elements of the tooth enamel, dentin, or bone. By depositing the restoration material on a damaged portion of enamel, dentin, or bone, the damaged portion may thus be restored. In an embodiment, the restoration material is a nano-scale powder suitable for being introduced into the ionizing plasma stream. The restoration material can comprise a variety of materials such as HAP, nano-scale diamonds, calcium apatite, or other minerals or materials. In an embodiment, the restoration material is exclusive of zircon-oxide, poly(methyl methacrylate), polyethylene, metal, or glass.
- Calcium apatite, Ca5(PO4)4(R), where R is an end-member, is a mineral produced and used by biological micro-environment systems. Species of calcium apatite include hydroxylapatite, Ca5(PO4)4(OH) (“HAP”), flourapatite, Ca5(PO4)4(F), and chlorapatite, Ca5(PO4)4(Cl). Portions of bone material comprise HAP wherein many of the OH groups are missing and contain many carbonate and acid phosphate substitutions. In an example, the restoration material is a nano-scale powder of HAP, carbonated calcium-deficient HAP with acid phosphate substitutions, or derivatives or substitutions thereof. In an embodiment, the manufactured nano-scale powders are dimensioned to approximately match a size of naturally occurring tooth enamel and bone crystals, for example 500 nm to 40 micrometers, such as 1 micrometer to 20 micrometers, or 2 micrometers to 10 micrometers. Thus, when deposited via plasma mediated deposition, the size of the nano-scale powder may promote crystallization of the restoration material that conforms with a crystalline structure of tooth enamel or bone. The restoration material should have ionic bonding qualities needed to achieve a non-toxic, biocompatible, permanent reconstruction of tooth and/or bone. It was also surprisingly found that the NTP deposition process causes additional crystallization in the restoration material.
- Introducing the restoration material via the
inlet 104 into the ionizing plasma stream in theionization chamber 102 forms a deposition stream. Thedeposition nozzle 106 receives the deposition stream, and shapes the plume of the deposition stream to conform to a desiredapplication site 108. The plume is ejected proximate to the application site, thus depositing bone restoration material on the application site. A distance between thedeposition nozzle 106 and the application site is selected such that bone restoration material adheres to, but does not damage the application site. Such distance may be calibrated based on, for example, a flow rate of the carrier gas, a flow rate of the restoration material, a size of the application site, and/or other factors. Example distances from the nozzle tip to theapplication site 108, include 0.001 mm to 5 mm, 0.01 mm to 3 mm, or 0.1 mm to 1.5 mm. - While the deposition stream is at a temperature that is not harmful to biological material, it may be desirable to deposit restoration material on the
application site 108 exclusive of any surrounding biological material. Thus, in an embodiment thedeposition nozzle 106 is configured to adjust a size and shape of the plume of the deposition stream. - In an embodiment, the
inlet 104 may be external and intersect with the plasma stream after it passes through thedeposition nozzle 106. - A desired
application site 108 may be, for example, a dental cavity, a bone fracture, a bone spur, a weakened or damaged portion of a tooth or bone, a degenerated disk, an arthritic joint, a void (or chip) in a tooth or bone, a groove in a teeth, such as may be caused by severe bruxism, or a combination thereof. - For treatment of bone damage, surgical techniques such as arthroscopic surgery may be adapted for use with the
device 100. - In an embodiment depicted in
FIG. 2 , anNTP deposition device 200 further comprises anexhaust hood 210 configured to vacate residue of the deposition stream from the application site 208 (which in this case is depicted as a cavity on a tooth surface) and/or provide at least a partial vacuum in the volume that is encompassed by theexhaust hood 210 and near theapplication site 208. Depending on the strength of the vacuum, the volume under vacuum may extend from a terminalcircumferential edge 212 of theexhaust hood 210 from 0.001 mm, to 5 mm, such as 0.01 mm to 2 mm, or 0.1 mm to 1 mm. - In an example, the
exhaust hood 210 uses suction or a vacuum to extract the residue. Theexhaust hood 210 may be a cup, hood, skirt, funnel or another structure configured to encapsulate thedeposition nozzle 106 and cover over theapplication site 208 so as to capture restoration material that does not adhere to bone or tooth and/or the ionized gasses in the deposition stream. Theexhaust hood 210 may comprise a rigid or flexible material. For example, the material may be a soft elastomeric material, a hard plastic material, a rigid metal material, or a soft, but stiff elastomer that will hold its form under vacuum, but will conform to theapplication site 208 if pushed against it. - In an embodiment, the
exhaust hood 210 is co-axial with and coupled to theionization chamber 106 or deposition nozzle 206 and circumscribing an area centered about thedeposition nozzle 106. A terminalcircumferential edge 212 of theexhaust hood 210 may extend 0.1 mm to 5 mm in radius about thedeposition nozzle 106, such as 0.5 mm to 2 mm, or 1 mm to 1.5 mm. The terminalcircumferential edge 212 may extend to be coplanar with a terminal end of thedeposition nozzle 207, or extend within 10 mm past a plane with the terminal end of thedeposition nozzle 207, such as 0.5 mm to 5 mm, or 1 mm to 1.5 mm. - The terminal
circumferential edge 212 of theexhaust hood 210 can be placed against theapplication site 208 so that thedeposition nozzle 106 and the plume are substantially or completely encapsulated. In an embodiment, thecircumferential edge 212 of theexhaust hood 210 is from 0.001 mm to 5 mm in proximity to theapplication site 208, such as 0.01 mm to 2 mm, or 0.1 mm to 1 mm. In an embodiment, thecircumferential edge 212 rests against the surrounding tissue or area around theapplication site 208. - In an embodiment, the
exhaust hood 210 is moveable in an axial direction along the outer surface of theionizing chamber 102 anddeposition nozzle 106. For example, theexhaust hood 210 may be coupled to theionizing chamber 102 through a sliding mechanism or a sliding and locking mechanism. InFIG. 2 , theexhaust hood 210 is concentrically fitted slideably coupled around theionization chamber 102 andnozzle 106. - In an embodiment, a tightened screw locking mechanism, such as a thumb screw, may be coupled to the
exhaust hood 210 and may be tightened against theionization chamber 102 and untightened to lock and unlock the slideable coupling. In another embodiment, the locking mechanism may be a tooth-in-groove structure or a reciprocating ratcheting mechanism. In an embodiment theexhaust hood 210 can be coupled to theionizing chamber 102 through a tight fitting cap or ring that is slideable along the outer surface of theionizing chamber 102. In an embodiment, theexhaust hood 210 is also configured to be locked into an axial position to prevent unwanted movement. This may be accomplished by known locking mechanisms for axially moveable parts, such as an insertable pin or lever that arrests movement in the axial direction. Axial rotation may also be prevented by known mechanisms including levers, pins, or detents. - The
vacuum exhaust outlet 213 is shown as extending up along the side of theionization chamber 102. The exhaust outlet may circumscribe the entire lower portion of theionization chamber 102 or only partially circumscribe a portion of it. In other embodiments, theexhaust outlet 213 is coupled to theexhaust hood 210 near thecircumferential edge 212 of theexhaust hood 210, such as 0.01 mm to 3 mm, 0.1 mm to 2 mm, or 0.5 mm to 1.5 mm from thecircumferential edge 212 of theexhaust hood 210. - The
exhaust outlet 213 is in communication with a vacuum device, such as an electric powered vacuum mechanism, or other known vacuum device. In an embodiment, the vacuum suction power (or pressure) is adjustable to levels desired to produce a vacuum that removes loose material and/or reduces heat build-up in the affected area. In an embodiment, the vacuum power is limited to a pressure that is less than a power that would disrupt the restoration material that is deposited onto theapplication site 208. In an embodiment, the vacuum power is high enough to affect the plasma deposition process, as certain plasma deposition processes may be enhanced in a vacuum environment. In an embodiment, the vacuum power is enough to remove debris, but has no effect on the deposition process. In an embodiment, the vacuum provides a drop from 99% to 1% of atmospheric pressure, e.g. (1 atm), such as 95% to 50%, or 90% to 75% of atmospheric pressure. - The
exhaust hood 210 may be adjustable so that the diameter of at least portions of theexhaust hood 210, including the terminalcircumferential edge 212, can be increased or decreased. This may be accomplished by using a structure similar to a camera aperture. Where multiple overlapping curvilinear panels are utilized to form the hood structure. In an embodiment, theexhaust hood 210 may be removable and replaceable with exhaust hoods of various shapes and features to adaptdevice 200 to the shape and conditions of the affected tooth, bone, or surrounding area. For example, the edge of a tooth, such as a bicuspid, may benefit from having an extended piece that wraps around the side of the tooth and where thevacuum exhaust outlet 213 is below the level of theapplication site 208 or to the side of theapplication site 208. - In an alternate embodiment, a structure similar to the
exhaust hood 210, such as a protective hood, is coupled to theNTP deposition device 200, but does not include anyexhaust outlet 213 or vacuum mechanism. In this embodiment the protective hood operates to merely protect surrounding tissue from deflected deposition material and heat. This option may be useful for operating on an application site that is locally numbed, if proper care is taken. The protective hood may also be combined with the camera and adjustability features described herein. - In another embodiment, shown in
FIG. 3 , anNTP deposition device 300 can further comprise acamera 314 configured to capture images of the deposition of the restoration material on the application site 308 (in this example a bone surface with a chip or fracture). Thecamera 314 may capture still or moving images of the deposition of the restoration material. Captured images may be used to show a before/after change resulting from the deposition, or may be used in diagnosis or patient evaluation. Additionally, captured images can be used to provide the operator of theNTP deposition device 300, such as a dentist, orthodontist, or surgeon with additional vision during the deposition process. In an example, a portion of the application site 308 may be obstructed from view of an individual using theNTP deposition device 300 by teeth, bone, other biological material, or theexhaust hood 210. An obstructed view can inhibit the accuracy, efficiency, and precision of the deposition, and can lead to waste of materials such as carrier gas and/or restoration deposition material. - Images captured from the
camera 314 disposed on theNTP deposition device 300 can, for example, be transmitted to and displayed on a video display visible by the operator using the NTP deposition device. - In an embodiment, at least a portion of the
camera 314 is disposed within theexhaust hood 210. As theexhaust hood 210 may obstruct the application site 308, disposing thecamera 314 within theexhaust hood 210 enables vision of the application site 308 while protecting surrounding biological material and evacuating residue of the deposition. Wiring oroptical cables 316 for thecamera 314 may run closely along the exterior of thedevice 300. - In an embodiment, the
camera 314 may be disposed opposite anexhaust outlet 213 within theexhaust hood 210 so as to reduce an amount of residue build-up on thecamera 314. - With reference now to
FIGS. 4 and 5 , various exemplary methodologies are illustrated and described. While the methodologies are described as being a series of acts that are performed in a sequence, it is to be understood that the methodologies are not limited by the order of the sequence. For instance, some acts may occur in a different order than what is described herein. In addition, an act may occur concurrently with another act. Furthermore, in some instances, not all acts may be required to implement a methodology described herein. - Referring now to
FIG. 4 , anexemplary methodology 400 that facilitates restoring bone, enamel, or combinations thereof via atmospheric plasma mediated deposition is illustrated. Themethodology 400 starts at 402, and at 404 a carrier gas is excited to form an atmospheric plasma stream. The carrier gas is a biocompatible, non-toxic gas, and can be excited via various techniques such as, for example, being exposed to a voltage difference across an ionization chamber. At 406, a restoration material is introduced into the plasma stream to form a deposition stream. The restoration material is as described above, a material that, when deposited on tooth or bone, crystallizes with a structure that comports with a crystalline structure of the tooth or bone. In an example, the restoration material is a nano-scale powder of hydroxyapatite. The restoration material may be introduced into the plasma stream via a variety of techniques such as, for example, spraying, aerosolizing, or mixing. - At 408, a plume of the deposition stream is directed to a desired application site. In an example, a nozzle shapes the plume to a size suitable for a particular application site such that surrounding biological material is protected from the deposition stream. At 410, restoration material is deposited on the application site by ejecting the plume proximate to the application site.
- Optionally, at 412, images of depositing restoration material on the application site are captured. Such images may be captured, for example, by a camera directed towards the application site and disposed proximate to the plume.
- At 414, bone or tooth damage at the application site are restored with the deposited restoration material. Restoration of the application site may include filling a void, such as a fracture, indentation, or crack back to its original state. For example, this may include filling the void up to a plane running across the highest edges of an indentation, fracture, or crack and possibly slightly exceeding the plane to substantially restore the original shape. For example, a crack may be filled within 10%, such as within 5%, or 2% of its volume or its distance over or beneath the plane.
- In an embodiment, the restoration is not a mere thin coating on the surface of the application site, nor is it an adhesive by which additional material is added. Rather, the restoration deposition has a substantial thickness and fills up a voided area that has suffered the loss of original material that has abraded, broken, or otherwise decayed away. In an embodiment, the restoration deposition has a thickness of 0.001 mm to 35 mm, 0.1 mm to 5 mm, or 10 mm to 25 mm.
- Optionally, at 416, residue of the deposition stream is vacated from the application site. The residue may be vacated by, for example, an exhaust hood, or vacuum, etc., disposed proximate to the plume. Residue may include, for example, excess restoration material, heat, and/or carrier gas. The methodology ends at 418.
- Referring now to
FIG. 5 , anexemplary methodology 500 that facilitates restoring a shape and mechanical integrity of a damaged portion of tooth or bone with hydroxyapatite is illustrated. Themethodology 500 starts at 502, and at 504, biocompatible nano-scale hydroxyapatite is adhered onto a damaged portion of a bone or tooth via biocompatible plasma mediated deposition. At 506, a shape and mechanical integrity of the damaged portion of tooth or bone is restored with the hydroxyapatite. At 508, biological material proximate to the damaged portion of tooth or bone is protected from the plasma mediated deposition. The methodology ends at 510. - In an embodiment of this
method 500, the restoration material is introduced after the deposition nozzle. For example, the restoration material may be deposited via a solution onto the application site and then ionized by the plasma gases that have no deposition material directly in the stream. - In an embodiment, a system or kit comprises a non-thermal plasma deposition device as disclosed herein. The system or kit also comprises one or more of the following: a restoration material, a supply container for the restoration material, a biocompatible carrier gas supply, a biocompatible carrier gas, an exhaust hood, a protective hood, a camera for capturing images of the restoration material deposition, a display for displaying the camera images, a vacuum device, a pressurization device, and conduits or wiring for connecting any of the components listed herein. The kit or system may be utilized to operate the methods for tooth or bone restoration disclosed herein.
- In Examples 1 and 2 deposition of hydroxylapatite with a non-thermal plasma deposition technique and device was demonstrated.
- Example 1
-
FIG. 6 shows an SEM photo that shows the hydroxylapatite restoration material deposited on and affixed to a Tagua surface, which is known to have similar properties to a human tooth. (See U.S. 2013/0224684, which is incorporated herein by reference for all purposes.) - Example 2
-
FIG. 7 is an SEM photo showing the hydroxylapatite crystals piling up in a significant thickness, such as would be useful to restore a damaged portion of tooth or bone by filling in a cracked, chipped, or otherwise damaged area. - Surprisingly, it was discovered that exciting the hydroxylapatite with a non-thermal plasma device produced new crystal growth in the deposited hydroxylapatite. This was observed in the figures as indicated by the angular crystalline features on the spherical particles and among them. This indicated new crystal growth and showed basic adhesion of the new crystals to old.
- What has been described above includes examples of one or more embodiments. It is, of course, not possible to describe every conceivable modification and alteration of the above devices or methodologies for purposes of describing the aforementioned aspects, but one of ordinary skill in the art can recognize that many further modifications and permutations of various aspects are possible. Accordingly, the described aspects are intended to embrace all such alterations, modifications, and variations that fall within the spirit and scope of the appended claims. The scope of the invention is not to be determined by the specific examples provided above but only by the claims below. In other instances, well-known structures, devices, and operations have been shown in block diagram form or without detail in order to avoid obscuring the understanding of the description. Where considered appropriate, reference numerals or terminal portions of reference numerals have been repeated among the figures to indicate corresponding or analogous elements, which may optionally have similar characteristics.
- It should also be appreciated that reference throughout this specification to “one embodiment”, “an embodiment”, “one or more embodiments”, or “different embodiments”, for example, means that a particular feature may be included in the practice of the invention. Similarly, it should be appreciated that in the description various features are sometimes grouped together in a single embodiment, figure, or description thereof for the purpose of streamlining the disclosure and aiding in the understanding of various inventive aspects. This method of disclosure, however, is not to be interpreted as reflecting an intention that the invention requires more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects may lie in less than all features of a single disclosed embodiment. Thus, the claims following the Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment of the invention.
Claims (20)
1. A method comprising:
exciting a carrier gas to form an atmospheric plasma stream; and
introducing a material into the plasma stream to form a deposition stream; and
depositing the material on an application site by ejecting a plume of the deposition stream to the application site;
wherein the material is a nano-scale powder or a solution comprising a nano-scale powder.
2. The method of claim 1 , wherein the material comprises a metal.
3. The method of claim 1 , further comprising capturing images of depositing the material on the application site.
4. The method of claim 1 , wherein the restoration material that is deposited on the on the application site is deposited at a thickness of 0.001 mm to 0.1 mm.
5. The method of claim 1 , further comprising applying to the application site, wherein the vacuum is at a pressure that is less than a pressure that would disrupt the restoration material that is deposited onto the application site but is high enough to enhance the step of directing the plasma stream onto the restoration material on the application site.
6. The method of claim 1 , wherein the material comprises a polymerizable material (or monomer).
7. The method of claim 1 , wherein, the carrier gas is ambient air.
8. A method for repairing a damaged bone or tooth, the method comprising:
exciting a carrier gas to form an atmospheric plasma stream;
depositing a restoration material onto an application site; and then
directing a plasma stream onto the restoration material on the application site; wherein the application site is a damaged area of a tooth or bone;
wherein the restoration material comprises a nano-scale powder or a solution comprising a nano-scale powder of hydroxyapatite.
9. The method of claim 8 wherein the plasma mediated deposition is conducted at a biocompatible temperature.
10. The method of claim 8 , further comprising restoring a shape and a mechanical integrity of the damaged portion of the bone or tooth with the restoration material.
11. The method of claim 8 , further comprising protecting biological material proximate to the damaged portion of the bone or tooth by vacating residue of the plasma mediated deposition, isolating the plasma mediated deposition from proximate biological material using a hood, shaping the plasma mediated deposition to conform to the damaged portion of the tooth or bone using a nozzle, or combinations thereof.
12. The method of claim 8 , further comprising crystallizing the restoration material when the plasma stream is directed onto the restoration material on the application site.
13. The method of claim 8 , further comprising applying a vacuum at the application site that is 0.99 atm to 0.01 atm.
14. A method comprising:
ionizing a material by subjecting the material to radiation, thereby optionally effecting polymerization;
wherein the material is a nano-scale powder or a solution comprising a nano-scale powder.
15. The method of claim 14 , wherein the material is hydroxyapatite, carbonated calcium-deficient hydroxyapatite with acid phosphate substitutions, calcium apatite, flourapatite, chlorapatite, or combinations thereof.
16. The method of claim 14 , wherein the material has a particle size of 500 nm to 40 micrometers.
17. The method of claim 14 , wherein the nano-scale powder is mixed with a carrier gas.
18. The method of claim 14 , wherein the step of ionizing the material causes polymerization of the material.
19. The method of claim 14 , wherein the material comprises a polymerizable material (or monomer).
20. The method of claim 14 , wherein the material comprises a mineral.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/299,844 US20230248988A1 (en) | 2013-01-22 | 2023-04-13 | Plasma deposition |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361755092P | 2013-01-22 | 2013-01-22 | |
PCT/US2014/012576 WO2014116722A1 (en) | 2013-01-22 | 2014-01-22 | Tooth and bone restoration via plasma deposition |
US14/398,619 US10384069B2 (en) | 2013-01-22 | 2014-01-22 | Tooth and bone restoration via plasma deposition |
US16/544,122 US11642542B2 (en) | 2013-01-22 | 2019-08-19 | Plasma deposition |
US18/299,844 US20230248988A1 (en) | 2013-01-22 | 2023-04-13 | Plasma deposition |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/544,122 Continuation US11642542B2 (en) | 2010-12-30 | 2019-08-19 | Plasma deposition |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230248988A1 true US20230248988A1 (en) | 2023-08-10 |
Family
ID=51227999
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/398,619 Active 2035-11-11 US10384069B2 (en) | 2010-12-30 | 2014-01-22 | Tooth and bone restoration via plasma deposition |
US16/544,122 Active 2035-08-04 US11642542B2 (en) | 2010-12-30 | 2019-08-19 | Plasma deposition |
US18/299,844 Pending US20230248988A1 (en) | 2013-01-22 | 2023-04-13 | Plasma deposition |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/398,619 Active 2035-11-11 US10384069B2 (en) | 2010-12-30 | 2014-01-22 | Tooth and bone restoration via plasma deposition |
US16/544,122 Active 2035-08-04 US11642542B2 (en) | 2010-12-30 | 2019-08-19 | Plasma deposition |
Country Status (3)
Country | Link |
---|---|
US (3) | US10384069B2 (en) |
EP (3) | EP3417827B1 (en) |
WO (1) | WO2014116722A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6010545B2 (en) | 2010-12-23 | 2016-10-19 | トゥエルヴ, インコーポレイテッド | System for mitral valve repair and replacement |
WO2014116722A1 (en) | 2013-01-22 | 2014-07-31 | Frederick Guy | Tooth and bone restoration via plasma deposition |
US11571584B2 (en) | 2010-12-30 | 2023-02-07 | Frederick R. Guy | Tooth and bone restoration via plasma deposition |
CN107496054B (en) | 2011-06-21 | 2020-03-03 | 托尔福公司 | Prosthetic heart valve devices and related systems and methods |
JP6151705B2 (en) | 2011-10-19 | 2017-06-21 | トゥエルヴ, インコーポレイテッド | Devices, systems and methods for heart valve replacement |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
CN114903657A (en) | 2011-10-19 | 2022-08-16 | 托尔福公司 | Prosthetic heart valve devices, prosthetic mitral valves, and related systems and methods |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
GB2501484A (en) * | 2012-04-24 | 2013-10-30 | Linde Ag | Plasma tooth treatment device |
CN108272536B (en) | 2013-05-20 | 2020-03-03 | 托尔福公司 | Implantable heart valve devices, mitral valve repair devices, and associated systems and methods |
EP3247179B1 (en) * | 2015-01-12 | 2020-12-30 | Shouguo Wang | Pluggable plasma discharge tube device |
DE102015212706A1 (en) * | 2015-07-07 | 2017-01-12 | Olympus Winter & Ibe Gmbh | Electrosurgical instrument for argon plasma coagulation and method of operation |
CN107920895B (en) | 2015-08-21 | 2020-06-26 | 托尔福公司 | Implantable heart valve devices, mitral valve repair devices, and associated systems and methods |
US11772126B2 (en) * | 2016-02-01 | 2023-10-03 | Theradep Technologies Inc. | Systems and methods for delivering therapeutic agents |
EP3448316B1 (en) | 2016-04-29 | 2023-03-29 | Medtronic Vascular Inc. | Prosthetic heart valve devices with tethered anchors |
EP3496515B1 (en) * | 2016-08-02 | 2022-09-28 | Feagle Co., Ltd | Medical device including plasma supply device and plasma enhancement member |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5249964A (en) * | 1988-12-21 | 1993-10-05 | Endo Technic Corporation International | Method for cutting metal bodies in the mouth |
US4917603A (en) * | 1989-01-30 | 1990-04-17 | Haack August F | Dental isolation system |
JP2830262B2 (en) | 1990-01-08 | 1998-12-02 | 住友化学工業株式会社 | Method for forming hydroxyapatite film |
US5609921A (en) | 1994-08-26 | 1997-03-11 | Universite De Sherbrooke | Suspension plasma spray |
US5676976A (en) | 1995-05-19 | 1997-10-14 | Etex Corporation | Synthesis of reactive amorphous calcium phosphates |
US7229436B2 (en) * | 1996-01-05 | 2007-06-12 | Thermage, Inc. | Method and kit for treatment of tissue |
US5873725A (en) * | 1996-11-12 | 1999-02-23 | Perler; Robert | Support post and method for coronal prosthesis |
JP3896437B2 (en) | 1997-12-08 | 2007-03-22 | 独立行政法人産業技術総合研究所 | Method for producing calcium phosphate coating |
US6270342B1 (en) * | 1999-07-28 | 2001-08-07 | Ceramoptec Industries, Inc. | Dental laser treatment hand-piece and system |
JP4221847B2 (en) * | 1999-10-25 | 2009-02-12 | パナソニック電工株式会社 | Plasma processing apparatus and plasma lighting method |
JP2002224142A (en) | 2001-01-31 | 2002-08-13 | Gc Corp | Method for making dental prosthesis |
US6915964B2 (en) | 2001-04-24 | 2005-07-12 | Innovative Technology, Inc. | System and process for solid-state deposition and consolidation of high velocity powder particles using thermal plastic deformation |
EP1275442A1 (en) | 2001-07-13 | 2003-01-15 | Stichting voor de Technische Wetenschappen | Electrostatic spray deposition (ESD) of biocompatible coatings on metallic substrates |
US6849306B2 (en) * | 2001-08-23 | 2005-02-01 | Konica Corporation | Plasma treatment method at atmospheric pressure |
US6770266B2 (en) | 2002-05-24 | 2004-08-03 | Colgate Palmolive Company | Liquid tooth whitening composition |
US7064089B2 (en) * | 2002-12-10 | 2006-06-20 | Semiconductor Energy Laboratory Co., Ltd. | Plasma treatment apparatus and method for plasma treatment |
WO2004071327A1 (en) * | 2003-02-06 | 2004-08-26 | Pentron Clinical Technologies, Llc | Method of manufacturing dental posts, obturators and restorations |
US20060251795A1 (en) * | 2005-05-05 | 2006-11-09 | Boris Kobrin | Controlled vapor deposition of biocompatible coatings for medical devices |
US7985072B2 (en) * | 2004-09-29 | 2011-07-26 | Rejuvedent Llc | Method and apparatus for tooth rejuvenation and hard tissue modification |
US20080280260A1 (en) | 2004-09-29 | 2008-11-13 | Belikov Andrei V | Method and Apparatus for Tooth Rejuvenation and Hard Tissue Modification |
EP2154937A2 (en) * | 2004-11-05 | 2010-02-17 | Dow Corning Ireland Limited | Plasma system |
US8071083B2 (en) * | 2004-12-13 | 2011-12-06 | Progentix Orthobiology B.V. | Tissue regeneration |
CA2651200C (en) * | 2005-03-07 | 2015-11-03 | Old Dominion University | Plasma generator |
US20100047733A1 (en) * | 2005-07-12 | 2010-02-25 | Sialo-Lite Ltd. | Device, system and method for procedures associated with the intra-oral cavity |
RU2314769C2 (en) * | 2005-08-05 | 2008-01-20 | Виктор Петрович Усов | Method and device for contact-free discrete-coherent cold plasma coagulation |
CA2547043C (en) * | 2005-08-05 | 2014-07-29 | Mcgill University | A plasma source and applications thereof |
US7687098B1 (en) | 2005-08-26 | 2010-03-30 | Charlie W. Chi | Chemical mechanical vapor deposition device for production of bone substitute material |
WO2007059038A2 (en) | 2005-11-14 | 2007-05-24 | Biomet 3I, Inc. | Deposition of discrete nanoparticles on an implant surface |
US8287914B2 (en) | 2006-01-12 | 2012-10-16 | Rutgers, The State University Of New Jersey | Biomimetic hydroxyapatite synthesis |
US7749555B2 (en) * | 2006-01-25 | 2010-07-06 | Medtronic, Inc | Modification of chemical forces of bone constructs |
US20070259427A1 (en) * | 2006-03-27 | 2007-11-08 | Storey Daniel M | Modified surfaces for attachment of biological materials |
WO2008049108A1 (en) | 2006-10-19 | 2008-04-24 | Northwestern University | Surface-independent, surface-modifying, multifunctional coatings and applications thereof |
DE102007061624A1 (en) * | 2007-05-31 | 2009-06-25 | Ernst-Moritz-Arndt-Universität Greifswald | Process for coating surfaces with microparticles and nanoparticles by means of plasma processes and their use |
WO2008157372A2 (en) * | 2007-06-14 | 2008-12-24 | Massachusetts Institute Of Technology | Self assembled films for protein and drug delivery applications |
WO2009029734A2 (en) * | 2007-08-28 | 2009-03-05 | Pioneer Surgical Technology, Inc. | Cement products and methods of making and using the same |
SE532685C2 (en) * | 2007-11-06 | 2010-03-16 | Tigran Technologies Ab Publ | Grains or granules for the treatment of a damaged vertebra |
JP5441066B2 (en) * | 2008-07-18 | 2014-03-12 | 株式会社吉田製作所 | Dental medical device and dental plasma jet irradiation device |
US10299887B2 (en) * | 2009-04-23 | 2019-05-28 | Nanova, Inc. | Atmospheric non-thermal gas plasma method for dental surface treatment |
CN101619434B (en) * | 2009-05-12 | 2011-04-13 | 四川大学 | Method for preparing porous hydroxylapatite coating by suspending liquid plasma spraying |
GB0909183D0 (en) * | 2009-05-28 | 2009-07-08 | Bedi Kathryn J | Coating method |
CA2771783C (en) | 2009-08-21 | 2018-08-28 | Ajay P. Malshe | Nanostructured hydroxyapatite coating for dental and orthopedic implants |
US8821504B2 (en) * | 2009-11-20 | 2014-09-02 | Zimmer Knee Creations, Inc. | Method for treating joint pain and associated instruments |
AU2010349785B2 (en) | 2010-03-31 | 2014-02-27 | Colorado State University Research Foundation | Liquid-gas interface plasma device |
US9339387B2 (en) * | 2010-10-13 | 2016-05-17 | Cibor, Inc. | Synthetic bone grafts constructed from carbon foam materials |
AU2011325965A1 (en) | 2010-11-12 | 2013-07-04 | Frederick R. Guy | Dental devices |
WO2014116722A1 (en) | 2013-01-22 | 2014-07-31 | Frederick Guy | Tooth and bone restoration via plasma deposition |
US9131597B2 (en) * | 2011-02-02 | 2015-09-08 | Arthrocare Corporation | Electrosurgical system and method for treating hard body tissue |
US8920361B2 (en) * | 2011-04-05 | 2014-12-30 | The Texas A&M University System | Plasma treatment and plasma enhanced chemical vapor deposition onto temperature sensitive biological materials |
DE102011052118A1 (en) * | 2011-07-25 | 2013-01-31 | Eckart Gmbh | Method for applying a coating to a substrate, coating and use of particles |
US9138187B2 (en) * | 2011-08-07 | 2015-09-22 | Zimmer Knee Creations, Inc. | Treatment of subchondral bone by biochemical diagnosis to prevent the progression of osteoarthritis of the joint |
US20180223260A1 (en) * | 2011-10-21 | 2018-08-09 | Stemgenics, Inc. | Functionalized nanoparticles for the intracellular delivery of biologically active molecules and methods for their manufacture and use |
EP2819620A4 (en) * | 2012-02-29 | 2015-11-04 | 206 Ortho Inc | Method and apparatus for treating bone fractures, including the use of composite implants |
RU2015109276A (en) * | 2012-09-14 | 2016-11-10 | Колд Плазма Медикал Текнолоджиз, Инк. | THERAPEUTIC APPLICATION OF COLD PLASMA |
EP3795635A1 (en) * | 2013-05-23 | 2021-03-24 | 206 ORTHO, Inc. | Apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants |
TW201507735A (en) * | 2013-08-16 | 2015-03-01 | Ind Tech Res Inst | Plasma generator, surface treatment method using the same and surface treatment method using the same for bio-tissue |
AU2014331769B2 (en) * | 2013-10-09 | 2019-01-24 | Lifenet Health | Compressed bone composition and methods of use thereof |
-
2014
- 2014-01-22 WO PCT/US2014/012576 patent/WO2014116722A1/en active Application Filing
- 2014-01-22 EP EP18179630.1A patent/EP3417827B1/en active Active
- 2014-01-22 US US14/398,619 patent/US10384069B2/en active Active
- 2014-01-22 EP EP22193003.5A patent/EP4129230A1/en not_active Withdrawn
- 2014-01-22 EP EP14743617.4A patent/EP2948094B1/en active Active
-
2019
- 2019-08-19 US US16/544,122 patent/US11642542B2/en active Active
-
2023
- 2023-04-13 US US18/299,844 patent/US20230248988A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2948094A1 (en) | 2015-12-02 |
EP3417827B1 (en) | 2022-08-31 |
WO2014116722A1 (en) | 2014-07-31 |
US10384069B2 (en) | 2019-08-20 |
US20150111170A1 (en) | 2015-04-23 |
EP4129230A1 (en) | 2023-02-08 |
EP2948094B1 (en) | 2018-06-27 |
EP2948094A4 (en) | 2016-09-14 |
EP3417827A1 (en) | 2018-12-26 |
US11642542B2 (en) | 2023-05-09 |
US20190366112A1 (en) | 2019-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230248988A1 (en) | Plasma deposition | |
Park et al. | The effects of ion beam-assisted deposition of hydroxyapatite on the grit-blasted surface of endosseous implants in rabbit tibiae. | |
de Oliveira et al. | Influence of diamond sono-abrasion, air-abrasion and Er: YAG laser irradiation on bonding of different adhesive systems to dentin | |
US20230330428A1 (en) | Sustainable material and method of making | |
Mello et al. | Osteoblast proliferation on hydroxyapatite thin coatings produced by right angle magnetron sputtering | |
US9968704B2 (en) | Method for regenerating alveolar bone and calcium-containing microparticles used to regenerate alveolar bone | |
US6339913B1 (en) | Method for improving the osteointegration of osseus fixing implants | |
Ogiso et al. | Differences in microstructural characteristics of dense HA and HA coating | |
Cho et al. | Evaluation of structural and mechanical properties of aerosol-deposited bioceramic films for orthodontic brackets | |
KR101882667B1 (en) | Self-detaching layer for easy implant removal | |
RU2458707C1 (en) | Method for making intraosseous dental implant with ion-beam modification of plasma-deposited multilayer bioactive coating | |
US11382840B2 (en) | Method for creating a mineral trioxide aggregate material with improved biological effects | |
Zhang et al. | Er: YAG laser debonding of porcelain laminate veneers | |
US20070258910A1 (en) | Methods and devices for remineralization of hard tissues | |
KR101296591B1 (en) | Post treatment device for ha coating layer of dental implant surface | |
KR100931668B1 (en) | Hydroxyapatite Coated Low Elastic Titanium Alloy Implant | |
KR102198363B1 (en) | Evaluation method of structural and mechanical properties of aerosol deposited bioceramic films for orthodontic brackets | |
JP5858527B2 (en) | Thin film forming equipment | |
Kaban et al. | Effect of Cold Atmospheric Plasma Treatment on the Bond Strength of Glass Fiber Posts | |
Stan et al. | Adherent glass-ceramic thin layers with bioactive potential deposited by magnetron sputtering techniques | |
RU48475U1 (en) | DENTAL IMPLANT | |
JP3318407B2 (en) | Titanium sprayed biological implant material | |
Engqvist et al. | L. Hemlansson, AE Abom Uppsala University Linkoping University | |
Kursoglu et al. | Effect of Er, Cr: YSGG laser on ceramic surface | |
Grenoble | Residual stress evaluation at bone implant interface using high energy x-ray diffraction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |